Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
Total Assignments:
1
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16617721
|
Filing Dt:
|
11/27/2019
|
Publication #:
|
|
Pub Dt:
|
04/30/2020
| | | | |
Inventors:
|
Michael D. Kaufman, Bryan D. Smith, Daniel L. Flynn, Oliver Rosen
|
Title:
|
USE OF 1-[4-BROMO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDIN-3-YL]-2-FLUOROPHENYL]-3-PHENYLUREA AND ANALOGS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA
|
|
Assignment:
1
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
200 SMITH STREET |
WALTHAM, MASSACHUSETTS 02451 |
|
|
|
GOODWIN PROCTER LLP |
100 NORTHERN AVENUE |
IP DOCKETING DEPT./7TH FL |
BOSTON, MA 02210 |
|
|
Search Results as of:
05/15/2024 03:47 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|